As the most reliable and balanced news aggregation service on the internet, DML News App offers the following information published by NBCNews.com:
The maker of OxyContin, Purdue Pharma, and its owners, the Sackler family, are offering to settle more than 2,000 lawsuits against the company for $10 billion to $12 billion. The potential deal was part of confidential conversations and discussed by Purdue’s lawyers at a meeting in Cleveland last Tuesday, Aug. 20, according to two people familiar with the mediation.
Brought by states, cities and counties, the lawsuits — some of which have been combined into one massive case — allege the company and the Sackler family are responsible for starting and sustaining the opioid crisis.
The article goes on to state the following:
At least 10 state attorneys general and the plaintiffs’ attorneys gathered in Cleveland, where David Sackler represented the Sackler family, according to two people familiar with the meeting. David Sackler, who was a board member of the company, has recently been the de facto family spokesperson.
Purdue Pharma is accused of deceptive their practices which were at least partly responsible for the opioid crisis. According to the Centers for Disease Control and Prevention, the crisis claimed more than 400,000 lives from 1999 to 2017.
How did Purdue Pharma incentivize its sales reps to sell OxyCotin?
We just got video of Richard Sackler’s deposition from a case Kentucky brought against Purdue Pharma. https://t.co/IBSGhb94hD
Here’s his answer to that question: pic.twitter.com/e5MIBv4V2i
— ProPublica (@propublica) August 27, 2019
BREAKING: Purdue Pharma and its owners, the Sackler family, offer to settle 2,000+ opioid-related lawsuits for $10B to $12B – @NBCNews
— CNBC Now (@CNBCnow) August 27, 2019
— The Hill (@thehill) August 27, 2019
JUST IN: OxyContin maker Purdue Pharma in discussions to settle opioid legal claims for $10 billion to $12 billion – sources pic.twitter.com/dYDj7F0dcH
— Reuters Business (@ReutersBiz) August 27, 2019
To get more information about this article, please visit NBCNews.com.